Vanderbilt Law Review, March 1st, 2005
Current international patent rules strike an uneasy balance between conflicting views about patents. The precarious nature of this balancing act is illustrated by the recent heated debate about the conditions under which compulsory licenses will be available for certain essential medicines under the Trade Related Aspects of Intellectual Property (TRIPS) agreement. That debate produced a compromise that will do little to fix the essential medicines problem. This Article argues that the recent debate was misplaced because it ignored differing elasticities of demand between developed and develop...
HighBeam Research, Free Preview: 'Patents, Essential Medicines, and the Innovation Game'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
